​

TG Therapeutics (TGTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

TG Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$141.15M

Main Segment (Y)

Product

Main Geography (Y)

Worldwide

TG Therapeutics Revenue by Period

TG Therapeutics Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$233.66M8290.02%
2022-12-31$2.79M-58.36%
2021-12-31$6.69M4300.66%
2020-12-31$152.00K-
2019-12-31$152.00K-
2018-12-31$152.00K-0.25%
2017-12-31$152.38K-
2016-12-31$152.38K-
2015-12-31$152.38K-
2014-12-31$152.38K-
2013-12-31$152.38K699.98%
2012-12-31$19.05K100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31-100.00%
2004-12-31-100.00%
2003-12-31--100.00%
2002-12-31$500.00K-81.56%
2001-12-31$2.71M-49.39%
2000-12-31$5.36M346.58%
1999-12-31$1.20M-60.00%
1998-12-31$3.00M2900.00%
1997-12-31$100.00K-
1996-12-31$100.00K-

TG Therapeutics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

TG Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$141.15M16.79%
2025-03-31$120.86M11.71%
2024-12-31$108.19M28.98%
2024-09-30$83.88M14.17%
2024-06-30$73.47M15.74%
2024-03-31$63.47M44.35%
2023-12-31$43.97M-73.48%
2023-09-30$165.81M931.57%
2023-06-30$16.07M106.00%
2023-03-31$7.80M9653.75%
2022-12-31$80.00K-14.89%
2022-09-30$94.00K-84.18%
2022-06-30$594.00K-70.54%
2022-03-31$2.02M-13.14%
2021-12-31$2.32M14.33%
2021-09-30$2.03M31.39%
2021-06-30$1.54M94.83%
2021-03-31$793.00K1986.84%
2020-12-31$38.00K-
2020-09-30$38.00K-
2020-06-30$38.00K-
2020-03-31$38.00K-
2019-12-31$38.00K-
2019-09-30$38.00K-
2019-06-30$38.00K-
2019-03-31$38.00K-
2018-12-31$38.00K-
2018-09-30$38.00K-
2018-06-30$38.00K-
2018-03-31$38.00K-0.25%
2017-12-31$38.09K-0.00%
2017-09-30$38.10K0.00%
2017-06-30$38.09K-
2017-03-31$38.09K-
2016-12-31$38.09K-0.00%
2016-09-30$38.10K0.00%
2016-06-30$38.09K-
2016-03-31$38.09K-
2015-12-31$38.09K-0.00%
2015-09-30$38.10K0.00%
2015-06-30$38.09K-
2015-03-31$38.09K-
2014-12-31$38.09K-0.00%
2014-09-30$38.10K0.00%
2014-06-30$38.09K-
2014-03-31$38.09K-
2013-12-31$38.09K-0.00%
2013-09-30$38.10K0.00%
2013-06-30$38.09K-
2013-03-31$38.09K99.99%
2012-12-31$19.05K100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31-100.00%
2007-09-30--

TG Therapeutics generated $141.15M in revenue during Q2 2025, up 16.79% compared to the previous quarter, and up 222.37% compared to the same period a year ago.

TG Therapeutics Revenue Breakdown

TG Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21
Other Revenue$1.82M$1.50M--
Product$313.73M$92.00M--
Royalty$801.00K---
Milestone$12.50M---
License Revenue$152.00K$140.15M--
License revenue--$152.00K$152.00K
Product revenue, net--$2.63M$6.54M

TG Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (95.36%), Milestone (3.80%), Other Revenue (0.55%), Royalty (0.24%), and License Revenue (0.05%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
License Revenue$2.31M$38.00K$76.00K$38.00K$38.00K------------
Product$138.84M$119.66M$179.94M$83.30M$50.49M$66.94M$25.07M$1.51M$755.00K--------
Other Revenue-$558.00K$1.09M$315.00K$415.00K------------
Royalty-$605.00K$539.00K$229.00K$33.00K------------
Milestone---$12.50M-------------
License------$140.75M$38.00K$38.00K--------
License revenue-------$38.00K$38.00K$38.00K$38.00K$38.00K$38.00K$38.00K$38.00K--
Product revenue, net-------$16.04M$7.76M$42.00K$56.00K$556.00K$1.98M$2.28M$1.99M--

TG Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (98.37%), and License Revenue (1.63%).

TG Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23
Worldwide$313.73M$92.00M
International$3.71M$3.22M

TG Therapeutics's latest annual revenue breakdown by geography, as of Dec 24: Worldwide (98.83%), and International (1.17%).

TG Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALKSAlkermes$1.56B$390.66M
PTCTPTC Therapeutics$806.78M$1.18B
AXSMAxsome Therapeutics$385.69M$150.04M
KRYSKrystal Biotech$290.51M$96.04M
ACLXArcellx$107.94M$8.13M
RNAAvidity Biosciences$10.90M$1.57M
ARWRArrowhead Pharmaceuticals$3.55M$542.71M
PTGXProtagonist Therapeutics-$28.32M
TGTXTG Therapeutics-$141.15M
PCVXVaxcyte--
MTSRMetsera--

TGTX Revenue FAQ

What is TG Therapeutics’s yearly revenue?

TG Therapeutics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $233.66M, representing an increase of 8290.02% compared to 2022. TGTX's yearly revenue for 2022 was $2.78M, representing a decrease of -58.36% compared to 2021.

What is TG Therapeutics’s quarterly revenue?

TG Therapeutics's quarterly revenue for Q2 2025 was $141.15M, a 16.79% increase from the previous quarter (Q1 2025), and a 92.13% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $120.86M, a 11.71% increase from the previous quarter (Q4 2024), and a 90.40% increase year-over-year (Q1 2024). TGTX's quarterly revenue for Q4 2024 was $108.18M, a 28.98% increase from the previous quarter (Q3 2024), and a 146.04% increase year-over-year (Q4 2023).

What is TG Therapeutics’s revenue growth rate?

TG Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are TG Therapeutics’s revenue streams?

TG Therapeutics's revenue streams in c 24 are Other Revenue, Product, Royalty, Milestone, and License Revenue. Other Revenue generated $1.82M in revenue, accounting 0.55% of the company's total revenue, up 21.21% year-over-year. Product generated $313.73M in revenue, accounting 95.36% of the company's total revenue, up 240.99% year-over-year. Royalty generated $801K in revenue, accounting 0.24% of the company's total revenue Milestone generated $12.5M in revenue, accounting 3.80% of the company's total revenue License Revenue generated $152K in revenue, accounting 0.05% of the company's total revenue, down -99.89% year-over-year.

What is TG Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of TG Therapeutics was Product. This segment made a revenue of $313.73M, representing 95.36% of the company's total revenue.